Medicine and Dentistry
Dithiothreitol
100%
Daratumumab
100%
Interference
100%
Blood Group ABO Incompatibility
100%
Neonatal Infant
100%
Erythrocyte
95%
Blood Group A Antibody
69%
Hemolysis
53%
Blood Stasis
50%
Blood Sampling
50%
Thrombocyte Function
50%
Assay
50%
Enalapril Maleate
50%
Protective Factor
50%
Alloantibody
49%
Reagent
42%
Therapeutic Procedure
33%
Patient
27%
Laboratory
25%
Hyperbilirubinemia
25%
Hospital
23%
Antibody
20%
Fetus
19%
Analysis
16%
Cells
16%
Phototherapy
16%
Childbirth
16%
Agonist
14%
Antibody Screening
11%
Screening Test
11%
Pregnancy
8%
First Trimester Pregnancy
8%
Screening
8%
Hemoglobin
8%
Hemolytic Anemia
8%
Accuracy
7%
Flow Cytometry
7%
Development
7%
Health Care Cost
7%
Adult
7%
Blood Clotting Factor
7%
Fibrinogen
7%
Tenidap
6%
Blood Transfusion
5%
Ensure
5%
Clinical Immunology
5%
Plasma
5%
Transfusion
5%
Biochemistry, Genetics and Molecular Biology
Hemolytic Disease of the Newborn (ABO)
100%
Antibody
70%
Blood Group ABO Incompatibility
57%
Development
57%
Blood Group O
54%
Titer
50%
Dithiothreitol
50%
Sample
39%
Association
37%
Pregnancy
25%
Screening
25%
Accuracy
24%
Experience
16%
Genotyping
16%
Blood Group B
16%
FUT2
16%
Blood Group
16%
Single-Nucleotide Polymorphism
16%
Genetics
16%
Birth
16%
Allele
11%
Time
10%
First Trimester Pregnancy
8%
Hemoglobin
8%
Flow Cytometry
7%
Screening Test
7%
Antibody Screening
7%
Blood Transfusion
5%
Immunology and Microbiology
Daratumumab
100%
Hemocyte
95%
Alloantibody
49%
Cells
16%
Monospecific Antibody
15%
Sample
15%
Screening Test
11%
Antibody Screening
11%
Time
10%
CD38
6%
Blood Transfusion
5%
Blood Plasma
5%